11-6621886-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_003737.4(DCHS1):c.9790C>T(p.Arg3264Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000323 in 1,612,384 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R3264H) has been classified as Uncertain significance.
Frequency
Consequence
NM_003737.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DCHS1 | NM_003737.4 | c.9790C>T | p.Arg3264Cys | missense_variant | 21/21 | ENST00000299441.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DCHS1 | ENST00000299441.5 | c.9790C>T | p.Arg3264Cys | missense_variant | 21/21 | 1 | NM_003737.4 | P1 | |
DCHS1-AS1 | ENST00000526456.1 | n.436G>A | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000446 AC: 11AN: 246692Hom.: 0 AF XY: 0.0000299 AC XY: 4AN XY: 133678
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1460062Hom.: 0 Cov.: 30 AF XY: 0.0000303 AC XY: 22AN XY: 726080
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74500
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 27, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 03, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 3264 of the DCHS1 protein (p.Arg3264Cys). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DCHS1 protein function. ClinVar contains an entry for this variant (Variation ID: 2192581). This variant has not been reported in the literature in individuals affected with DCHS1-related conditions. This variant is present in population databases (rs200963531, gnomAD 0.01%). - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2023 | The c.9790C>T (p.R3264C) alteration is located in exon 21 (coding exon 20) of the DCHS1 gene. This alteration results from a C to T substitution at nucleotide position 9790, causing the arginine (R) at amino acid position 3264 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at